Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications

Michael Zakrewsky, Amrita Banerjee, Sanjana Apte, Theresa L. Kern, Mattie R. Jones, Rico E Del Sesto, Andrew T Koppisch, David T. Fox, Samir Mitragotri

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Antiseptic agents are the primary arsenal to disinfect skin and prevent pathogens spreading within the host as well as into the surroundings; however the Food and Drug Administration published a report in 2015 requiring additional validation of nearly all current antiseptic agents before their continued use can be allowed. This vulnerable position calls for urgent identification of novel antiseptic agents. Recently, the ability of a deep eutectic, Choline And Geranate (CAGE), to treat biofilms of Pseudomonas aeruginosa and Salmonella enterica was demonstrated. Here it is reported that CAGE exhibits broad-spectrum antimicrobial activity against a number of drug-resistant bacteria, fungi, and viruses including clinical isolates of Mycobacterium tuberculosis, Staphylococcus aureus, and Candida albicans as well as laboratory strains of Herpes Simplex Virus. Studies in human keratinocytes and mice show that CAGE affords negligible local or systemic toxicity, and an ≈180–14 000-fold improved efficacy/toxicity ratio over currently used antiseptic agents. Further, CAGE penetrates deep into the dermis and treats pathogens located in deep skin layers as confirmed by the ability of CAGE in vivo to treat Propionibacterium acnes infection. In combination, the results clearly demonstrate CAGE holds promise as a transformative platform antiseptic agent for preventive as well as therapeutic applications.

Original languageEnglish (US)
Pages (from-to)1282-1289
Number of pages8
JournalAdvanced healthcare materials
Volume5
Issue number11
DOIs
StatePublished - Jun 8 2016

Fingerprint

Local Anti-Infective Agents
Choline
Eutectics
Pathogens
Viruses
Toxicity
Skin
Therapeutics
Arsenals
Propionibacterium acnes
Salmonella
Salmonella enterica
Candida
Biofilms
Simplexvirus
United States Food and Drug Administration
Dermis
Fungi
Candida albicans
Keratinocytes

Keywords

  • antimicrobial resistance
  • antiseptics
  • beacterial infections
  • drug delivery
  • infection prevention

ASJC Scopus subject areas

  • Biomedical Engineering
  • Biomaterials
  • Pharmaceutical Science

Cite this

Zakrewsky, M., Banerjee, A., Apte, S., Kern, T. L., Jones, M. R., Sesto, R. E. D., ... Mitragotri, S. (2016). Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications. Advanced healthcare materials, 5(11), 1282-1289. https://doi.org/10.1002/adhm.201600086

Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications. / Zakrewsky, Michael; Banerjee, Amrita; Apte, Sanjana; Kern, Theresa L.; Jones, Mattie R.; Sesto, Rico E Del; Koppisch, Andrew T; Fox, David T.; Mitragotri, Samir.

In: Advanced healthcare materials, Vol. 5, No. 11, 08.06.2016, p. 1282-1289.

Research output: Contribution to journalArticle

Zakrewsky, M, Banerjee, A, Apte, S, Kern, TL, Jones, MR, Sesto, RED, Koppisch, AT, Fox, DT & Mitragotri, S 2016, 'Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications', Advanced healthcare materials, vol. 5, no. 11, pp. 1282-1289. https://doi.org/10.1002/adhm.201600086
Zakrewsky, Michael ; Banerjee, Amrita ; Apte, Sanjana ; Kern, Theresa L. ; Jones, Mattie R. ; Sesto, Rico E Del ; Koppisch, Andrew T ; Fox, David T. ; Mitragotri, Samir. / Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications. In: Advanced healthcare materials. 2016 ; Vol. 5, No. 11. pp. 1282-1289.
@article{dd94c68bfc924489bd5ee80a280b2679,
title = "Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications",
abstract = "Antiseptic agents are the primary arsenal to disinfect skin and prevent pathogens spreading within the host as well as into the surroundings; however the Food and Drug Administration published a report in 2015 requiring additional validation of nearly all current antiseptic agents before their continued use can be allowed. This vulnerable position calls for urgent identification of novel antiseptic agents. Recently, the ability of a deep eutectic, Choline And Geranate (CAGE), to treat biofilms of Pseudomonas aeruginosa and Salmonella enterica was demonstrated. Here it is reported that CAGE exhibits broad-spectrum antimicrobial activity against a number of drug-resistant bacteria, fungi, and viruses including clinical isolates of Mycobacterium tuberculosis, Staphylococcus aureus, and Candida albicans as well as laboratory strains of Herpes Simplex Virus. Studies in human keratinocytes and mice show that CAGE affords negligible local or systemic toxicity, and an ≈180–14 000-fold improved efficacy/toxicity ratio over currently used antiseptic agents. Further, CAGE penetrates deep into the dermis and treats pathogens located in deep skin layers as confirmed by the ability of CAGE in vivo to treat Propionibacterium acnes infection. In combination, the results clearly demonstrate CAGE holds promise as a transformative platform antiseptic agent for preventive as well as therapeutic applications.",
keywords = "antimicrobial resistance, antiseptics, beacterial infections, drug delivery, infection prevention",
author = "Michael Zakrewsky and Amrita Banerjee and Sanjana Apte and Kern, {Theresa L.} and Jones, {Mattie R.} and Sesto, {Rico E Del} and Koppisch, {Andrew T} and Fox, {David T.} and Samir Mitragotri",
year = "2016",
month = "6",
day = "8",
doi = "10.1002/adhm.201600086",
language = "English (US)",
volume = "5",
pages = "1282--1289",
journal = "Advanced healthcare materials",
issn = "2192-2640",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications

AU - Zakrewsky, Michael

AU - Banerjee, Amrita

AU - Apte, Sanjana

AU - Kern, Theresa L.

AU - Jones, Mattie R.

AU - Sesto, Rico E Del

AU - Koppisch, Andrew T

AU - Fox, David T.

AU - Mitragotri, Samir

PY - 2016/6/8

Y1 - 2016/6/8

N2 - Antiseptic agents are the primary arsenal to disinfect skin and prevent pathogens spreading within the host as well as into the surroundings; however the Food and Drug Administration published a report in 2015 requiring additional validation of nearly all current antiseptic agents before their continued use can be allowed. This vulnerable position calls for urgent identification of novel antiseptic agents. Recently, the ability of a deep eutectic, Choline And Geranate (CAGE), to treat biofilms of Pseudomonas aeruginosa and Salmonella enterica was demonstrated. Here it is reported that CAGE exhibits broad-spectrum antimicrobial activity against a number of drug-resistant bacteria, fungi, and viruses including clinical isolates of Mycobacterium tuberculosis, Staphylococcus aureus, and Candida albicans as well as laboratory strains of Herpes Simplex Virus. Studies in human keratinocytes and mice show that CAGE affords negligible local or systemic toxicity, and an ≈180–14 000-fold improved efficacy/toxicity ratio over currently used antiseptic agents. Further, CAGE penetrates deep into the dermis and treats pathogens located in deep skin layers as confirmed by the ability of CAGE in vivo to treat Propionibacterium acnes infection. In combination, the results clearly demonstrate CAGE holds promise as a transformative platform antiseptic agent for preventive as well as therapeutic applications.

AB - Antiseptic agents are the primary arsenal to disinfect skin and prevent pathogens spreading within the host as well as into the surroundings; however the Food and Drug Administration published a report in 2015 requiring additional validation of nearly all current antiseptic agents before their continued use can be allowed. This vulnerable position calls for urgent identification of novel antiseptic agents. Recently, the ability of a deep eutectic, Choline And Geranate (CAGE), to treat biofilms of Pseudomonas aeruginosa and Salmonella enterica was demonstrated. Here it is reported that CAGE exhibits broad-spectrum antimicrobial activity against a number of drug-resistant bacteria, fungi, and viruses including clinical isolates of Mycobacterium tuberculosis, Staphylococcus aureus, and Candida albicans as well as laboratory strains of Herpes Simplex Virus. Studies in human keratinocytes and mice show that CAGE affords negligible local or systemic toxicity, and an ≈180–14 000-fold improved efficacy/toxicity ratio over currently used antiseptic agents. Further, CAGE penetrates deep into the dermis and treats pathogens located in deep skin layers as confirmed by the ability of CAGE in vivo to treat Propionibacterium acnes infection. In combination, the results clearly demonstrate CAGE holds promise as a transformative platform antiseptic agent for preventive as well as therapeutic applications.

KW - antimicrobial resistance

KW - antiseptics

KW - beacterial infections

KW - drug delivery

KW - infection prevention

UR - http://www.scopus.com/inward/record.url?scp=84976589659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976589659&partnerID=8YFLogxK

U2 - 10.1002/adhm.201600086

DO - 10.1002/adhm.201600086

M3 - Article

C2 - 26959835

AN - SCOPUS:84976589659

VL - 5

SP - 1282

EP - 1289

JO - Advanced healthcare materials

JF - Advanced healthcare materials

SN - 2192-2640

IS - 11

ER -